Management of Hypertension

The management of hypertension in kidney diseases is for the most part in view of the administration of medications which can reduce proteinuria and to slowdowns the dynamic functional deterioration. Angiotensin-changing over chemical inhibitors (ACEI), which bring down both proteinuria and blood pressure, have developed as medications of choice in proteinuric patients with either typical renal function or mild to moderate  kidney failure. In non proteinuric nephropathies no controlled examinations exist showing the prevalence of ACEI over different medications. In these conditions calcium antagonists may likewise be utilized. The way to deal with patients with hypertension and renal illness ought to dependably take into consideration over the nature of the outcomes that are to be accomplished. If the aim is to lower proteinuria and slow down progression, at that point ACEI, conceivably connected with calcium adversaries, are the medications of choice.

 

  • Diabetes Management
  • Urogynecology
  • Glomerulonephritis
  • Lowering blood pressure

Related Conference of Management of Hypertension

June 22-23, 2020

5th World Kidney Congress

Abu Dhabi, UAE
August 20-21, 2020

16th World Nephrology Conference

Prague, Czech Republic
September 07-08, 2020

22nd World Nephrologists Summit

Tokyo, Japan
September 14-15, 2020

17th Asia Pacific Nephrology Conference

Osaka, Japan
September 16-17, 2020

15th Nephrology,Renal Medicine & Renal Care

Tokyo, Japan
October 12-13, 2020

24th European Nephrology Conference

Zurich, Switzerland
October 26-27, 2020

3rd International Conference on Nephrology

Dubai, UAE
November 09-10, 2020

International Conference on  Urology and Andrology

Bangkok, Thailand
November 23-24, 2020

World Congress and Expo on Nephrology

Hanoi, Vietnam

Management of Hypertension Conference Speakers

Recommended Sessions

Related Journals

Are you interested in